A-A-53522
10 June 1988
COMMERCIAL ITEM DESCRIPTION
AMINOPHYLLINE INJECTION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics.
Shall be Aminophylline Injection, USP.
Shall be Aminophylline Injection, USP, containing 25 mg per ml.
Shall be in accordance with the requirements of the USP.
Material used I manufacture shall be of pharmaceutical grade.
Workmanship. The solution shall be free from defects which detract from its appearance or impair its serviceability.
Unit.
For Size 1 – Package (PG). Shall be supplied 10 ml in a commercially available vial. One package containing 25 vials, as specified, constitutes one unit.
For Size 3 – Package (PG). Shall be 10 ml in a commercially available, clear, colorless, cylindrical, flat-bottom, graduated, threaded rubber stoppered glass vial with plastic lug cap. Each vial shall be packaged together with a translucent, plastic vial-injector containing a plastic cylinder, threaded at one end and attazched to the base of the injector barrel at the other, and a 22 gage X 1-1/2 inch needle guard and a plastic snap cap. The fluid pathway of all components shall be sterile. Shall be suitable for use with the Cardiopulmonary Resuscutator Kit, specified in the Note Section of this document. One package containing 10 disposable syringe-needle units, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business